bn:02048203n
Noun Concept
Categories: Triazoles, Abandoned drugs, Drugs not assigned an ATC code, Oxazoles, Tyrosine kinase inhibitors
EN
mubritinib  TAK-165  TAK165  TAK 165
EN
Mubritinib is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. Wikipedia
Definitions
Relations
Sources
EN
Mubritinib is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. Wikipedia
Wikipedia
Wikidata
Wikidata Alias